Clinical Trial Update: Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating amifostine to protect against side effects of peripheral stem cell transplantation in patients with solid tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Chordoma
• Germ Cell Tumor
• Kidney Cancer
• Liver Cancer
• Neuroblastoma
• Ovarian Cancer
• Retinoblastoma

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Status: TERMINATED